ISSN: 2167-7689
Pharmaceutical Regulatory Affairs: Open Access
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 

Comparison on Safety Concern Among Gamma-Ray, Autoclave and Ethylene Oxide Gas Sterilizations of Thermosetting Polyurethane

Hideharu Shintani*
Faculty of Science and Engineering, Chuo University, Tokyo, Japan
Corresponding Author : Hideharu Shintani
Faculty of Science and Engineering
Chuo University, 1-13-27, Kasuga
Bunkyo, 112-8551, Tokyo, Japan
Tel: +81425922336
Fax: +81425922336
E-mail: shintani@mail.hinocatv.ne.jp
Received September 01, 2014; Accepted September 02, 2014; Published September 04, 2014
Citation: Shintani H (2014) Comparison on Safety Concern Among Gamma-Ray, Autoclave and Ethylene Oxide Gas Sterilizations of Thermosetting Polyurethane. Pharmaceut Reg Affairs 3:e139 doi: 10.4172/2167-7689.1000e139
Copyright: © 2014 Shintani H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Pharmaceutical Regulatory Affairs: Open Access

Sterilization of polyurethane (PU) produces 4,4’-methylenedianiline (MDA), a known carcinogen, and various others including hydrophilic and hydrophobic compounds. The relationships between PU components and MDA formation by several methods of sterilization were confirmed using thermosetting PU. Specimens of PU fabricated from different combination of isocyanates and polyols were obtained from dialyzers (detailed omitted in this editorial). The molecular weight of the particular poluol was found to influence the production of MDA by sterilization. Sterilization also produced many unidentified compounds. MDA production was not always associated with the production of the other compounds. Compared with gamma-ray irradiation sterilization, ethylene oxide gas (EOG) sterilization, and autoclave sterilization, gamma-ray irradiation sterilization produced most MDA (Figure 1). This phenomenon was significant for PU produced from smaller molecular weight polyols. The combination of autoclave sterilization and a PU produced from a larger molecular weight polyols is recommended to minimize the production of potentially toxic compounds. Of the techniques studied, EOG sterilization produced the least amounts of MDA and the other compounds, but the residue of EOG is itself problematic. Sterilization produced more MDA from PUs fabricated with smaller-molecularweight polyols than from PUs fabricated from larger-molecular-weight polyols.
Seventeen peaks including that for MDA, were observed in HPLC chromatograms of the sterilized PU samples (Figure 2). Comparing gamma-ray sterilization with autoclave sterilization, autoclave sterilization tended to produce greater amounts of hydrophilic compounds.
Various compounds of unknown composition were produced by the sterilization of PU. However, the amounts of the unknown compounds produced varied depending on combinations of the sterilization methods and the components of PU; therefore, the hazardous effect of sterilization can be diminished by selecting an appropriate combination of sterilization method and PU components. As shown in the chromatogram, the combination of autoclave sterilization and a PU fabricated from a larger-molecular-weight polyol was observed to attain the least toxic compound production. Autoclave sterilization is desirable, although the number of polymers that can tolerate moist heat is limited. Among autoclave, gamma-ray, and EOG sterilization, EOG sterilization produced the smallest amounts of potentially toxic compounds, but there remains the problem of the carcinogenic EOG residue.
The biological safety as well as the chemical structures of the compounds other than MDA eluted after sterilization of PU must be identified to determine their carcinogenic potentials.
The risk posed by the amounts of MDA extracted was not significant, but the biological safety of the other compounds remains to be determined.
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc
Disc Advances in Bioavailability
Disc Advances in pharmaceutical analytical methods
Disc Adverse Effects
Disc Air analysis
Disc Anvisa Bioequivalence
Disc Anvisa regulatory guidelines
Disc BA/BE Studies
Disc Bioequivalence Anticancers
Disc Bioequivalence Antidiabetics
Disc Bioequivalence Antidiuretics
Disc Bioequivalence Antipsychotics
Disc Bioequivalence Cardiovascular Products
Disc Bioequivalence Study Design
Disc Bioequivalence Study Protocols
Disc Biopharmaceutics
Disc Biosimilars
Disc British regulatory guidelines
Disc Causality Assesment
Disc Chemical analysis
Disc Clinical Cancer Trials
Disc Clinical Drug Trial
Disc Clinical Pharmacovigilance
Disc Clinical Trials Pharmacovigilance
Disc Competitive analysis of drugs
Disc Drug Monitoring
Disc Drug Safety Survillance
Disc Drug analysis
Disc Drug devices
Disc Europe Pharmacovigilance
Disc European Bioequivalence
Disc Europian regulatory guidelines
Disc Experimental Drug Trial
Disc FDA Bioequivalence
Disc Good Pharmacovigilance Practice
Disc In vitro Bioequivalence
Disc Japan Pharmacovigilance
Disc Japan regulatory guidelines
Disc Medical Literature
Disc Medical devices regulations
Disc Medication Error
Disc Paid Clinical Trials
Disc Periodic Safety Update Reports
Disc Pharma Risk Management
Disc Pharmaceutical analysis
Disc Pharmaceutical analytical market
Disc Pharmaceutical care
Disc Pharmaceutical companies and regulatory guidelines
Disc Pharmaceutical ethics
Disc Pharmaceutical formulation
Disc Pharmaceutical technology
Disc Pharmaceutics
Disc Pharmacovigilance Regulatory Updates
Disc Pharmacovigilance and Risk Management
Disc Pharmacovigilance for Alternative Medicine
Disc Product analysis and marketing
Disc Quality assurance in pharmaceutical analysis
Disc Quality assurance in regulatory affairs
Disc Regulatory Requirements in Bioequivalence
Disc Regulatory affairs
Disc Regulatory affairs for clinical trails
Disc Regulatory compliance
Disc Regulatory consulting and market analysis
Disc Regulatory requirements of pharmaceutical products
Disc Regulatory services and market analysis
Disc Spectrometry
Disc UK Pharmacovigilance
Disc US FDA guidelines
Disc US Pharmacovigilance
Disc Validation
Disc Veterinary Pharmacovigilance
 
Recommended Journals
Disc Pharmacovigilance Journal
Disc Pharmaceutical Analysis Journal
Disc Bioequivalence Journal
  View More»
 
Recommended Conferences
Disc African Pharma Congress
June 20-22, 2016, Cape Town, South Africa
Disc 6th Pharmaceutical Regulatory Affairs
September 15-16, 2016, San Antonio, USA
Disc 7th Analytical Techniques Conference
September 29-Oct 1, 2016, Miami, USA
Disc Pharmaceutical Methods Development Conference
October 20-22, 2016, Dubai, UAE
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11182
  [From(publication date):
December-2014 - May 26, 2016]
  Breakdown by view type
  HTML page views : 7452
  PDF downloads :3730
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version